About SeLux Diagnostics
SeLux Diagnostics is a company based in Cambridge (United States) founded in 2014.. SeLux Diagnostics has raised $161.01 million across 11 funding rounds from investors including NIH, HHS and RA Capital. SeLux Diagnostics offers products and services including Selux NGP System, Selux Analyzer, and Selux Panels. SeLux Diagnostics operates in a competitive market with competitors including Cepheid, Day Zero Diagnostics, Specific Technologies, SpinDiag and InSilixa, among others.
- Headquarter Cambridge, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Selux Diagnostics, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$161.01 M (USD)
in 11 rounds
-
Latest Funding Round
$48 M (USD), Series C
Feb 01, 2024
-
Investors
NIH
& 6 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SeLux Diagnostics
SeLux Diagnostics offers a comprehensive portfolio of products and services, including Selux NGP System, Selux Analyzer, and Selux Panels. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides rapid antibiotic susceptibility testing for infectious diseases.
Offers precise cell health analysis for fast AST results.
Facilitates comprehensive menu for antimicrobial resistance testing.
Unlock access to complete
Unlock access to complete
Funding Insights of SeLux Diagnostics
SeLux Diagnostics has successfully raised a total of $161.01M across 11 strategic funding rounds. The most recent funding activity was a Series C round of $48 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 11
- Last Round Series C — $48.0M
-
First Round
First Round
(01 Apr 2016)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2024 | Amount | Series C - SeLux Diagnostics | Valuation | RA Capital Management | |
| Feb, 2022 | Amount | Series C - SeLux Diagnostics | Valuation | RA Capital Management | |
| Oct, 2021 | Amount | Grant - SeLux Diagnostics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in SeLux Diagnostics
SeLux Diagnostics has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, HHS and RA Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm investing in life sciences & tech sectors
|
Founded Year | Domain | Location | |
|
Active, long-term growth equity investments are provided globally.
|
Founded Year | Domain | Location | |
|
Private equity investments are directed across multiple sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by SeLux Diagnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - SeLux Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Selux Diagnostics Comparisons
Competitors of SeLux Diagnostics
SeLux Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cepheid, Day Zero Diagnostics, Specific Technologies, SpinDiag and InSilixa, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of molecular diagnostic testing solutions
|
|
| domain | founded_year | HQ Location |
Genome sequencing diagnostics for infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Detection and antibiotic susceptibility testing for blood infections are provided.
|
|
| domain | founded_year | HQ Location |
Point-of-care systems for screening drug-resistant pathogens are developed.
|
|
| domain | founded_year | HQ Location |
Develops innovative point-of-care diagnostics using semiconductor-based CMOS biochip technology.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Selux Diagnostics
Frequently Asked Questions about SeLux Diagnostics
When was SeLux Diagnostics founded?
SeLux Diagnostics was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Where is SeLux Diagnostics located?
SeLux Diagnostics is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Is SeLux Diagnostics a funded company?
SeLux Diagnostics is a funded company, having raised a total of $161.01M across 11 funding rounds to date. The company's 1st funding round was a Grant of $2.8M, raised on Apr 01, 2016.
What does SeLux Diagnostics do?
Developer of alternatives to traditional ELISA assays. The company claims that its novel assay replaces the use of enzymes with an alternative that makes it more sensitive and faster than traditional ELISAs. Applications include point-of-care assays that have sensitivity similar to clinical laboratories.
Who are the top competitors of SeLux Diagnostics?
SeLux Diagnostics's top competitors include Cepheid, Day Zero Diagnostics and Specific Technologies.
What products or services does SeLux Diagnostics offer?
SeLux Diagnostics offers Selux NGP System, Selux Analyzer, and Selux Panels.
Who are SeLux Diagnostics's investors?
SeLux Diagnostics has 7 investors. Key investors include NIH, HHS, RA Capital, Northpond Ventures, and Sands Capital.